Synovus Financial Corp Ligand Pharmaceuticals Inc Transaction History

Synovus Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$89.56 - $126.72 $2,059 - $2,914	-23 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$68.28 - $123.65 $6,623 - $11,994	-97 Reduced 80.83%	23 $3,000
Q1 2020 Apr 24, 2020	BUY	$63.37 - $107.88 $6,146 - $10,464	97 Added 421.74%	120 $9,000
Q3 2018 Nov 01, 2018	BUY	$211.18 - $274.49 $4,857 - $6,313	23 New	23 $6,000

256

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.